Resources

15 Resources for

company and pivotal corp.

Subscribe to this listing via:
RSS
Email

Show All Related Tags Did you mean Prudential Insurance Company of America (7,588 results), Dow Jones & Company Inc. (4,374 results), insurance company (2,898 results), retail company (1,668 results), pharmaceutical company (1,394 results)more...

Show Fewer Related Tags Did you mean Prudential Insurance Company of America (7,588 results), Dow Jones & Company Inc. (4,374 results), insurance company (2,898 results), retail company (1,668 results), pharmaceutical company (1,394 results), cable company (669 results), automobile company (516 results), telecommunications company (432 results), financial company (185 results), software company (135 results), oil company (123 results), Investment Company Institute (99 results), telephone company (97 results), investment company (92 results), fund company (77 results), chemical company (76 results), Great Atlantic & Pacific Tea Company Inc. (64 results), Public Company Accounting Oversight Board (64 results), drug company (59 results), online retail company (56 results), technology company (55 results), venture-capital company (48 results), media company (44 results), outsourcing company (43 results), U.S. company (41 results), chip company (40 results), food company (40 results), health care company (38 results), bank holding company (37 results), consulting company (37 results), energy company (37 results), computer company (36 results), gas company (33 results), Chinese company (33 results), Internet company (30 results), private equity company (30 results), electronics company (28 results), PC company (27 results), record company (26 results), tobacco company (25 results), steel company (25 results), auto company (24 results), credit card company (22 results), financial services company (21 results), banking company (20 results), high-technology company (20 results), Fast Company (19 results), information technology company (19 results), satellite company (18 results), mobile phone company (17 results)fewer...

BNET Resources

Accentia Biopharmaceuticals Makes Milestone Payment Based on Fast Tracked Pivotal Phase 3 Study with SinuNase for the Treatment of Chronic Sinusitis: European Patent Office Communicates Grant of Key Patent for European Union Company Extends Control of the Exclusive Worldwide Rights to All Prescription Antifungals TAMPA, Fla. -- Accentia Biopharmaceuticals Inc. (NASDAQ: ABPI; "Accentia") has made a milestone payment to the Mayo Foundation for Medical Education and Research ("Mayo") for...; Tags: Accentia Biopharmaceuticals Inc., Biovest International Inc., Company, European Patent Office, FDA, Government, patient, payment, Pivotal Corp.; Research articles 2007-05-14
Guardian Technologies Announces Pivotal Test Results Validating Company's Proprietary Technology Significantly Improves Breast Cancer Mammograms: Company's Signature Mapping[TM] Demonstrates Unprecedented Detection Rate of Lesions with 97.5% Accuracy vs. 80% for Existing Procedures; Tags: breast cancer, Company, Pivotal Corp.; Research articles 2007-07-13
MIV Therapeutics Announces Pivotal Test Results Further Validating Company Stent Coatings Meet Critical FDA Fatigue Guidelines: Bench Test Merged Biosync Stent Platform with Company's Biocompatible Coating, Validating Milestone Acquisition of India-Based Subsidiary; Tags: Company, FDA, Pivotal Corp.; Research articles 2007-04-05
Pivotal Self Service Technologies Sets Date for Annual General Meeting: TORONTO -- Pivotal Self-Service Technologies Inc. (OTCBB:PVSS) is pleased to announce that the Company's Annual General Meeting has been set for June 28, 2004. The Board of Directors has declared the record date as June 14, 2004 and the mailing of the meeting materials is scheduled for June...; Tags: Company, Pivotal Corp.; Research articles 2004-06-16
Pivotal Self-Service Technologies Shareholders Ratify Phantom Fiber Acquisition: TORONTO -- On June 28, 2004, Pivotal Self-Service Technologies Inc. (OTCBB:PVSS) held its Annual Meeting of Shareholders. At the meeting, the shareholders ratified the acquisition of Phantom Fiber Corporation, including the election of Jeffrey Halloran, Gordon Fowler, Graham Simmonds and Stephen Gesner as directors of the Company at closing of...; Tags: Company, Pivotal Corp., shareholder; Research articles 2004-06-28

Icagen Provides Update on Status of Enrollment in Pivotal Phase III Trial of ICA-17043: RESEARCH TRIANGLE PARK, N.C. -- Icagen, Inc. (NASDAQ: ICGN) today announced that the Company has recently met the seventy five percent point of enrollment in the Company's pivotal Phase III trial of ICA-17043 for the chronic oral treatment of sickle cell disease, with 225 of the total expected study population...; Tags: Company, enrollment, Pivotal Corp.; Research articles 2006-06-21
A.P. Pharma Expects Data from APF530 Pivotal Trial in Second Half of 2007: REDWOOD CITY, Calif. -- A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical company, today announced that it expects to have initial data from its Phase 3 clinical trial with APF530 in the second half of 2007, and plans to file a New Drug Application NDA with the U.S. Food and Drug...; Tags: Company, enrollment, patient, Pivotal Corp.; Research articles 2006-09-28
Isotechnika Completes Patient Recruitment of Pivotal Phase 3 Psoriasis Trial.: EDMONTON, Canada, July 23 /PRNewswire/ -- Isotechnika Inc. (TSX:ISA) announced today that the Company has completed recruitment of its pivotal Phase 3 European/Canadian psoriasis trial ESSENCE. As of July 20, 2007, the Company closed recruitmen EDMONTON, Canada, July 23 /PRNewswire/ -- ...; Tags: Company, patient, Pivotal Corp., recruitment; Research articles 2007-07-23
Pivotal Veracity Unveils Critical Brand Monitoring and Protection Tool; Imperative for Corporations to Ensure Brand Credibility in Online Marketing Activities: SARASOTA, Fla. -- Pivotal Veracity, LLC, an independent email delivery audit and optimization company, today introduced eBrand Monitor, a new tool to help organizations easily and comprehensively monitor their greatest assets, protect their reputation and safeguard the viability of their email communications. eBrand Monitor tracks a company's domains, IP addresses,...; Tags: brand, company, marketing, Pivotal Corp., tool; Research articles 2004-10-04
BioSyntech Receives Approval for Canadian BST-Cargel'R' Pivotal Clinical Trial.: LAVAL, QUEBEC, Nov 16, 2005 CCNMatthews via COMTEX -- BioSyntech, Inc. ("BioSyntech" or "the Company") (TSX VENTURE:BSY) announced today that it has received approval from Health Canada, Therapeutic Products Directorate, Medical LAVAL, QUEBEC, Nov 16, 2005 CCNMatthews via COMTEX -- BioSyntech, Inc. ("BioSyntech" or "the...; Tags: clinical trial, Company, Pivotal Corp.; Research articles 2005-11-16
PIVOTAL MOVE: Internet guru Red Burns has joined Pivot Rules' board.: NEW YORK, NEW YORK RATINGS GET HOT IN ETHNIC MARKET New York's ethnic radio stations are playing musical chairs, with the most recent Arbitron data showing WQHT, or Hot 97, taking the top spot away from WSKQ, the Spanish station that became No. 1 thisNEW YORK,...; Tags: board, company, Internet, Pivotal Corp.; Research articles 1998-09-21
Positive Interim Safety Results of Pivotal Trial of Nymox's NX-1207 For Benign Prostatic Hyperplasia: HASBROUCK HEIGHTS, N.J. -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce that interim safety analysis of its ongoing multi-center Phase 2 trial of NX-1207 has thus far revealed no serious drug side effects. NX-1207 is Nymox's lead drug candidate for the treatment of benign prostatic hyperplasia BPH which the...; Tags: Company, Pivotal Corp.; Research articles 2005-08-04
Theratechnologies: Last Patient Treated in Pivotal TH9507 Trial.(Clinical report): MONTREAL, QUEBEC, Oct 25, 2006 CCNMatthews via COMTEX -- Theratechnologies (TSX:TH) announced today that it has completed the efficacy phase (26 weeks of treatment) of its first Phase 3 clinical trial testing TH9507 in HIV-associated lipodystrophy. MONTREAL, QUEBEC, Oct 25, 2006 CCNMatthews via COMTEX -- ...; Tags: Company, patient, Pivotal Corp.; Research articles 2006-10-25
Positive Interim Safety Results of Pivotal Trial of Nymox's NX-1207 For Benign Prostatic Hyperplasia.: HASBROUCK HEIGHTS, N.J., Aug 4, 2005 CCNMatthews via COMTEX -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce that interim safety analysis of its ongoing multi-center Phase 2 trial of NX-1207 has thus far revealed no serious HASBROUCK HEIGHTS, N.J., Aug 4, 2005 (CCNMatthews via...; Tags: Company, Pivotal Corp.; Research articles 2005-08-04
SangStat Initiates Pivotal Bioequivalence Trials for CYCLOSPORINE: MENLO PARK, Calif.--BUSINESS WIRE--July 15, 1996--SangStat, The Transplant CompanyTM (NASDAQ: SANG), announced today that it has initiated pivotal bioequivalence trials with its CYCLOSPORINE formulation. This formulation was selected based on positive results from pilot bioequivalence trials completed earlier this year. The Company expects to complete the pivotal trials...; Tags: Company, formulation, Pivotal Corp.; Research articles 1996-07-15

Additional Resources

Yahoo's fate riding on Yang's CEO successor: SAN FRANCISCO -- With Jerry Yang quitting as Yahoo Inc.'s chief executive, the Internet company's board will confront pivotal questions as it looks for a new leader. Should Yahoo swallow its pride and try to strike a buyout deal with Microsoft Corp. at a price far below...; Articles 2008-11-19
pSivida Corp. Reports Results for the First Quarter Ended September 30, 2008: WATERTOWN, Mass. -- pSivida Corp. (NASDAQ:PSDV)(ASX:PVA)(FF:PV3), a drug delivery company, today announced financial results for the first quarter ended September 30, 2008. For the quarter ended September 30, 2008, the Company reported a consolidated net loss of $471,000, or $0.03 per share, compared to a consolidated net loss...; Articles 2008-11-11
BioMS Medical Announces Third Quarter 2008 Results: Toronto Stock Exchange Symbol: MS EDMONTON, Nov. 6 /PRNewswire-FirstCall/ -- BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis MS, today announced financial and operational results for the third quarter ended September 30, 2008. BioMS Medical, in partnership with Eli Lilly and...; Articles 2008-11-06
BioMS Medical to present at Rodman and Renshaw Annual Healthcare Conference: Toronto Stock Exchange Symbol: MS EDMONTON, Nov. 5 /PRNewswire-FirstCall/ -- BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis MS, today announced that Mr. Kevin Giese, President and CEO, will present at the Rodman and Renshaw 10th Annual Healthcare Conference in New...; Articles 2008-11-05
BioMS Medical's phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board: Toronto Stock Exchange Symbol: MS EDMONTON, Oct. 3 /PRNewswire-FirstCall/ -- BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis MS, today announced that the independent Data Safety Monitoring Board DSMB for the Company's U.S. pivotal phase III MAESTRO-03 trial of dirucotide (MBP8298)...; Articles 2008-10-03

<< Previous
page 1 of 1
Next >>

Resources

company and pivotal corp.

BNET Resources

Additional Resources

Premier Vendor Content Whitepapers, webcasts & resources from our Power Center Sponsors